Biomarkers in Systemic Sclerosis-Related Pulmonary Arterial Hypertension

Publisher： Bentham Science Publishers

E-ISSN： 1875-6212|9|2|213-219

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.9, Iss.2, 2011-01, pp. : 213-219

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

N-Terminal probrain natriuretic peptide as a biochemical marker in the evaluation of bosentan treatment in systemic-sclerosis-related pulmonary arterial hypertension

By Dimitroulas Theodoros   Giannakoulas Georgios   Karvounis Haralambos   Koliakos Georgios   Sfetsios Tilemahos   Dimitroula Hara   Settas Loukas  

Clinical Rheumatology, Vol. 27, Iss. 5, 2008-05 ,pp. : 655-658

Springer Publishing Company

Access to resources Recommend Favorite

Pulmonary Arterial Hypertension in Systemic Sclerosis: Clinical Manifestations, Pathophysiology, Evaluation, and Management

By Ramirez Allan  

Treatments in Respiratory Medicine, Vol. 3, Iss. 6, 2004-01 ,pp. : 339-352

Adis International

Access to resources Recommend Favorite

Systemic Sclerosis-Related Interstitial Lung Disease

By  

Current Respiratory Medicine Reviews, Vol. 4, Iss. 3, 2008-08 ,pp. : 226-232

Bentham Science Publishers

Access to resources Recommend Favorite

Difficulties in diagnosis of systemic sclerosis‐related interstitial lung disease

By  

Respirology Case Reports, Vol. 3, Iss. 3, 2015-09 ,pp. : 99-101

John Wiley & Sons Inc

Access to resources Recommend Favorite

Survival of an elderly patient with limited cutaneous systemic sclerosis, pretamponade and pulmonary hypertension

By Naboush Ali   Abdallah Mokhtar   Asti Deepak   Goldstein Mark  

International Journal of Clinical Rheumatology, Vol. 8, Iss. 2, 2013-04 ,pp. : 159-163

Future Medicine

Access to resources Recommend Favorite